Q32 Bio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -91 | |||
EBITDA | -9,098 | -10,612 | 6,709 | -18,691 |
EBIT | -9,189 | -10,731 | 6,589 | -18,814 |
Net Income | -9,489 | -11,031 | -14,189 | -17,595 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,703 | -12,482 | -11,430 | -19,580 |
Cash | 54,832 | 65,483 | 77,965 | 89,078 |
Basic Shares | 12,197 | 12,197 | 12,180 | 12,076 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $-6,651 | $6,651 | $33,971 |
Gross Profit | -487 | -7,229 | 4,052 | 24,427 |
EBITDA | -45,300 | -47,756 | -38,855 | -86,220 |
EBIT | -45,787 | -48,255 | -41,454 | -95,764 |
Net Income | -47,733 | -53,743 | -42,809 | -37,564 |
Net Change In Cash | 0 | -6,651 | 6,651 | 33,971 |
Free Cash Flow | -67,790 | -96,458 | -13,442 | -33,136 |
Cash | 77,965 | 39,266 | 43,893 | 32,247 |
Basic Shares | 9,657 | 3,218 | 3,188 | 3,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.78 |
2025-03-31 | -$0.90 |
2024-12-31 | -$1.16 |
2024-09-30 | -$1.45 |
